Compromised Microcirculation in Women With Polycystic Ovary Syndrome
Status: | Completed |
---|---|
Conditions: | Ovarian Cancer, Women's Studies |
Therapuetic Areas: | Oncology, Reproductive |
Healthy: | No |
Age Range: | 18 - 35 |
Updated: | 1/1/2014 |
Start Date: | February 2008 |
End Date: | December 2012 |
Contact: | Nina Stachenfeld, PhD |
Email: | nstach@jbpierce.org |
Phone: | 203 562-9901 |
The scientific aims of the study are to determine how peripheral microcirculatory
responsiveness is altered in obese women with Polycystic Ovary Syndrome (PCOS) during local
heating and to determine the mechanism for testosterone effects on peripheral
microcirculatory responsiveness in women with PCOS.
responsiveness is altered in obese women with Polycystic Ovary Syndrome (PCOS) during local
heating and to determine the mechanism for testosterone effects on peripheral
microcirculatory responsiveness in women with PCOS.
In these studies, we propose to use the skin as a relatively non-invasive model to examine
cardiovascular and endothelial function in obese women with and without PCOS. Data have
indicated an important role for testosterone in influencing the peripheral microcirculation.
While testosterone can lead to vasodilation in the peripheral microcirculation in both men
and in women without PCOS, testosterone appears to induce vasoconstriction in women with
PCOS. The differential response between women with and without PCOS, and between men and
women may be the result of differential ET-1 actions in the vessel, and regulated by the
receptor subtype is involved in these actions.
cardiovascular and endothelial function in obese women with and without PCOS. Data have
indicated an important role for testosterone in influencing the peripheral microcirculation.
While testosterone can lead to vasodilation in the peripheral microcirculation in both men
and in women without PCOS, testosterone appears to induce vasoconstriction in women with
PCOS. The differential response between women with and without PCOS, and between men and
women may be the result of differential ET-1 actions in the vessel, and regulated by the
receptor subtype is involved in these actions.
Inclusion Criteria:
- Obese women (18-35) years with and without PCOS
Exclusion Criteria:
- Conditions that would preclude safe use of hormones
We found this trial at
1
site
Click here to add this to my saved trials